Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
12.46
-0.69 (-5.25%)
May 13, 2025, 4:00 PM - Market closed
Centessa Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 383.22 | 128.03 | 393.64 | 595.08 | 7.23 | Upgrade
|
| Short-Term Investments | 98.96 | 128.52 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 482.18 | 256.55 | 393.64 | 595.08 | 7.23 | Upgrade
|
| Cash Growth | 87.95% | -34.83% | -33.85% | 8134.15% | - | Upgrade
|
| Other Receivables | 45.3 | 39.15 | 26.72 | 16.81 | 2.93 | Upgrade
|
| Receivables | 45.3 | 39.15 | 26.72 | 16.81 | 2.93 | Upgrade
|
| Prepaid Expenses | 0.84 | 1.65 | 2.79 | 4.66 | 0.01 | Upgrade
|
| Other Current Assets | 8.1 | 17.74 | 14.59 | 12.22 | 1 | Upgrade
|
| Total Current Assets | 536.41 | 315.09 | 437.75 | 628.77 | 11.17 | Upgrade
|
| Property, Plant & Equipment | 11.76 | 12.95 | 1.17 | 0.16 | - | Upgrade
|
| Long-Term Deferred Tax Assets | 26.59 | 29.65 | 3.51 | - | - | Upgrade
|
| Other Long-Term Assets | 2.05 | 2.55 | 1.88 | 0.7 | 0.55 | Upgrade
|
| Total Assets | 576.8 | 360.25 | 444.31 | 629.64 | 11.72 | Upgrade
|
| Accounts Payable | 7.14 | 11.82 | 13.84 | 8.07 | 1.03 | Upgrade
|
| Accrued Expenses | 49.31 | 26.62 | 22.23 | 15.7 | 1.04 | Upgrade
|
| Short-Term Debt | - | - | - | - | 5.63 | Upgrade
|
| Current Portion of Leases | 0.6 | - | - | - | - | Upgrade
|
| Current Income Taxes Payable | 0.84 | 0.11 | 1.58 | 0.77 | - | Upgrade
|
| Other Current Liabilities | 0.11 | 0.84 | 0.69 | 0.1 | 0.92 | Upgrade
|
| Total Current Liabilities | 58 | 39.39 | 38.34 | 24.64 | 8.62 | Upgrade
|
| Long-Term Debt | 108.94 | 75.7 | 69.8 | 75.7 | - | Upgrade
|
| Long-Term Leases | 8.29 | 8.89 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.03 | 0.03 | - | 37.74 | - | Upgrade
|
| Total Liabilities | 175.25 | 124 | 108.14 | 138.08 | 8.62 | Upgrade
|
| Common Stock | 0.36 | 0.27 | 0.27 | 0.25 | 25.55 | Upgrade
|
| Additional Paid-In Capital | 1,386 | 987.42 | 939.26 | 876.27 | 0.83 | Upgrade
|
| Retained Earnings | -988.7 | -752.95 | -601.86 | -385.65 | -23.85 | Upgrade
|
| Comprehensive Income & Other | 4.21 | 1.49 | -1.5 | 0.69 | 0.57 | Upgrade
|
| Shareholders' Equity | 401.55 | 236.24 | 336.17 | 491.55 | 3.1 | Upgrade
|
| Total Liabilities & Equity | 576.8 | 360.25 | 444.31 | 629.64 | 11.72 | Upgrade
|
| Total Debt | 117.83 | 84.59 | 69.8 | 75.7 | 5.63 | Upgrade
|
| Net Cash (Debt) | 364.35 | 171.96 | 323.84 | 519.38 | 1.6 | Upgrade
|
| Net Cash Growth | 111.88% | -46.90% | -37.65% | 32361.38% | - | Upgrade
|
| Net Cash Per Share | 3.18 | 1.79 | 3.47 | 6.91 | 0.11 | Upgrade
|
| Filing Date Shares Outstanding | 133.18 | 100.31 | 94.96 | 94.02 | 15 | Upgrade
|
| Total Common Shares Outstanding | 132.63 | 98.77 | 94.84 | 89.99 | 15 | Upgrade
|
| Working Capital | 478.41 | 275.71 | 399.41 | 604.14 | 2.55 | Upgrade
|
| Book Value Per Share | 3.03 | 2.39 | 3.54 | 5.46 | 0.21 | Upgrade
|
| Tangible Book Value | 401.55 | 236.24 | 336.17 | 491.55 | 3.1 | Upgrade
|
| Tangible Book Value Per Share | 3.03 | 2.39 | 3.54 | 5.46 | 0.21 | Upgrade
|
| Machinery | 1.54 | 1.5 | 0.44 | 0.2 | - | Upgrade
|
| Construction In Progress | - | - | 0.89 | - | - | Upgrade
|
Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.